The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2019
Filed:
Dec. 08, 2017
Applicant:
Biomet Biologics, Llc, Warsaw, IN (US);
Inventors:
Matthew D. Landrigan, Fort Wayne, IN (US);
Krista Toler, Pierceton, IN (US);
Jennifer E. Woodell-May, Warsaw, IN (US);
David L. Suter, Rochester Hills, MI (US);
Assignee:
Biomet Biologics, LLC, Warsaw, IN (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/19 (2006.01); A61K 35/15 (2015.01); A61K 35/19 (2015.01); A61K 38/17 (2006.01); A61K 35/14 (2015.01); A61K 38/18 (2006.01);
U.S. Cl.
CPC ...
A61K 38/19 (2013.01); A61K 35/14 (2013.01); A61K 35/15 (2013.01); A61K 35/19 (2013.01); A61K 38/1703 (2013.01); A61K 38/1793 (2013.01); A61K 38/1808 (2013.01); A61K 38/1858 (2013.01);
Abstract
Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-β1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.